CERVICO-FACIAL HEMANGIOMAS; THE TREATMENT THAT ELUDES US

AbstractCervicofacial hemangiomas treated from January 2001 to December 2009 was clinically evaluated. This retrospective clinical study consisted of 42 females and 20 males with the age ranged from 20 days to 55 years. The lesions were present with-in first month in 45 patients (72.6%). Two patterns of tumor growth were evident: focal and diffuse. There were 59 focal hemangiomas (80.8%) and 14 diffuse hemangiomas (19.2%). Complications noted at the time of first consultation include residual skin changes in the in 35 patients (56.5%), obstruction of orifices in 14 patients (22.6%), ulceration in 6 patients (9.7%), and infection occurred in 2 patients (3.2%). Overall, there is reduction in size and improvement in color and texture of lesion following intervention in each group. No significant difference in outcome was observed in between groups with respect to change in size and texture. However, improvement in color showed statistically significant difference and combined treatment modality and surgical treatment was found to be better.

Download Full-text

Peri-Implant Bone Loss at Implants Placed in Preserved Alveolar Bone Versus Implants Placed in Native Bone: A Retrospective Radiographic Study

The Open Dentistry Journal ◽

10.2174/1874210601812010529 ◽

2018 ◽

Vol 12 (1) ◽

pp. 529-545 ◽

Cited By ~ 2

Author(s):

Johann Bui Quoc ◽

Aurélie Vang ◽

Laurence Evrard

Keyword(s):

Clinical Study ◽

Bone Loss ◽

Alveolar Bone ◽

Control Group ◽

Radiographic Study ◽

Platelet Concentrates ◽

Native Bone ◽

Retrospective Clinical Study ◽

Significant Difference ◽

Edentulous Patients

Objectives: The aim of our study was to compare peri-implant bone loss at implants placed in alveolar sockets filled with a particulate allogenous bone graft (DFDBA 300-500 µm) and platelet concentrates versus at implants placed in the native bone. Materials and Methods: A retrospective clinical study was performed. A total of 84 patients were included with 247 implants for the restoration of mono and pluri-radicular teeth: 169 implants in native bone and 78 in socket-grafted bone. The peri-implant bone loss was measured by 2 independent operators at 6 and 12 months. Results: The overall mesial and distal peri-implant bone losses were 0.9 ± 0.7 mm and 0.9 ± 0.8 mm at 6 months, respectively, and 1 ± 0.65 mm and 1.2 ± 0.9 mm at 12 months, respectively. In the tested group, the bone loss was 0.8 ± 0.8 mm at 6 months and 1.2 ± 0.9 mm at 12 months. In the control group, the bone loss was 1.0 ± 0.7 mm at 6 months and 0.95 ± 0.6 mm at 12 months. There were no statistically significant differences in bone loss between the two groups. Taking both groups together, there were no statistically significant difference in bone loss between patients with or without histories of periodontitis, but there was a statistically significant difference in bone loss between the mandible and maxilla as well as between unitary and total edentations and between partially and total edentulous patients. Conclusion: At 6 and 12 months, the peri-implant bone loss in sockets preserved with DFDBA and platelet concentrates was similar to the peri-implant bone loss in native bone.

Download Full-text

Combined Treatment Method Comparison Of Medical And Surgical Treatment In Idiopathic Granulomatous Mastitis

International Journal Of Medical Science And Clinical Invention ◽

10.18535/ijmsci/v5i4.05 ◽

2018 ◽

Vol 5 (4) ◽

pp. 3737-3742

Author(s):

Ebubekir Gündeş ◽

Mehmet Aykut Yildirim ◽

Tevfik Küçükkartallar ◽

Faruk Aksoy ◽

Ahmet Tekin ◽

...

Keyword(s):

Surgical Treatment ◽

Combined Treatment ◽

Granulomatous Mastitis ◽

Selective Treatment ◽

Idiopathic Granulomatous Mastitis ◽

Therapy Algorithm ◽

Group I ◽

Significant Difference ◽

The Mean

Aim: Our aim in conducting this study was to ascertain the clinical, pathological, and radiological characteristics of patients diagnosed with idiopathic granulomatous mastitis in our clinic and to contribute to related literature by creating a therapy algorithm for granulomatous mastitis. Method: A total of 62 patients diagnosed with granulomatous mastitis in our clinic were classified into three groups as per the mode of treatment they received. Among these, 20 patients who had only been administered corticosteroids were allocated to Group I, while 18 patients who had received surgical treatment in addition to corticosteroid treatment were allocated to Group II, and 24 patients who had only received surgery were allocated to Group III. Results: All the cases were female patients. The mean age of the patients was 33.67 ± 6.35 (21-48). No statistically significant difference was found among the groups as per the mean age figures, pregnancy, breastfeeding, oral contraceptive administration, smoking and alcohol use, and family history (p>0.05). 49 (77.4%) patients were diagnosed with granulomatous mastitis by thick-needle biopsy, 7 (11.2%) by incisional biopsy, 4 (6.4%) by excisional biopsy, and 3 (4.8%) by fine-needle aspiration biopsy (FNAB) before the onset of treatment. The median value for the follow-up of the patients was 40 (6-81) months and there was no statistically significant difference among follow-up periods (p: 0.51). 15 (24.1%) patients among all the cases had recurrence. There was a statistically significant difference among the groups with regards to recurrence (p: 0.015). Conclusion: Granulomatous mastitis may simulate breast cancer both clinically and radiologically. Recurrence is observed in patients who only received corticosteroid or surgical treatment. The combination of corticosteroid and surgical treatment significantly reduces the rate of recurrence. Therefore, this combination can be recommended as selective treatment.

Download Full-text

The safety and efficiency of retroperitoneal laparoscopic adrenalectomy via extra and intra perinephric fat approaches: a retrospective clinical study

BMC Surgery ◽

10.1186/s12893-019-0648-8 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Xuejian Wang ◽

Junqiang Liu ◽

Aozhang Ji ◽

Changli Liu ◽

Sony Nahayo ◽

...

Keyword(s):

Clinical Study ◽

Laparoscopic Adrenalectomy ◽

Vena Cava ◽

Postoperative Management ◽

Organ Injury ◽

Adrenal Tumors ◽

Retrospective Clinical Study ◽

Significant Difference ◽

Post Operation ◽

Perinephric Fat

Abstract Background This retrospective clinical study is to evaluate the safety and efficiency of two different approaches in retroperitoneal laparoscopic adrenalectomy and provide experience and basis for the treatment of adrenal tumors through retroperitoneal approach. Methods From July 2015 to February 2018, 112 patients with adrenal lesions underwent retroperitoneal laparoscopic adrenalectomy (RLA) using a 3-port method. Among them, 56 patients underwent RLA via the extra perinephric fat approach (EPFA), 56 patients underwent RLA via the intra perinephric fat approach (IPFA). Clinical data, including preoperative, operative and postoperative management were recorded. Results All surgeries were successfully completed, and there was no single patient who died during these surgeries. There was no statistically significant difference between the two groups in blood loss, postoperative complications, vena cava injury, renal cortex injury, peripheral organ injury, and post operation hospital stay. Peritoneum injury occurred more frequently in the EPFA group when compared with the IPEA group (p = 0.042). The average surgery time of the IPEA group is significantly shorter when compared with that of the EPEA group (p < 0.001). Due to serious saponification of the perinephric fat and heavy adhesion to renal fascia, three cases in IPFA group were converted to the EPFA surgery. Conclusion RLA is a safe and effective procedure both via extra perinephric fat and intra perinephric fat approaches. IPEA is superior to EPEA in terms of peritoneal injury and duration. The choice may mainly depend on the experience of the surgeon, the characteristics of the adrenal tumor and the nature of the perinephric fat.

Download Full-text

Impact of Medical and Surgical Treatment of Endometriosis on the Cure of Endometriosis and Pain

BioMed Research International ◽

10.1155/2014/264653 ◽

2014 ◽

Vol 2014 ◽

pp. 1-9 ◽

Cited By ~ 15

Author(s):

Liselotte Mettler ◽

R. Ruprai ◽

Ibrahim Alkatout

Keyword(s):

Surgical Treatment ◽

Hormonal Therapy ◽

Treatment Options ◽

Combined Treatment ◽

Treatment Strategies ◽

Outcome Data ◽

Deep Infiltrating Endometriosis ◽

Cure Rate ◽

Significant Difference ◽

Group 2

This endometriosis study evaluates three different treatment strategies (hormonal medication, surgical, or combined treatment) and discusses the influence of endometriosis on the cure of this disease and pain relief. Four hundred and fifty patients with genital endometriosis, aged 18–44 years, were randomly distributed to three treatment groups at the first laparoscopy. They were reevaluated at a second-look laparoscopy (D 426/10), one to two months after the three-month hormonal therapy for groups 1 and 3 and five to six months later for group 2 (surgical treatment alone). Outcome data focussed on the recurrence of symptoms and pain. The three treatment options independent of the initial endoscopic endometriosis classification (EEC) stage including deep infiltrating endometriosis (DIE) achieved an overall cure rate of 50% or higher. The highest cure rate of 60% was achieved by the combined treatment, 55% by the exclusively hormonal therapy, and 50% by the exclusively surgical treatment. An overall pregnancy rate between 55% and 65% was achieved with no significant difference in relation to the therapeutical option.

Download Full-text

Retrospective Clinical Study of a Freely Removable Implant-Supported Fixed Dental Prosthesis by a Microlocking System

BioMed Research International ◽

10.1155/2020/7929585 ◽

2020 ◽

Vol 2020 ◽

pp. 1-7

Author(s):

Eun-Bin Bae ◽

Won-Tak Cho ◽

Hyun-Young Bae ◽

So-Hyoun Lee ◽

Tae-Hyung Kim ◽

...

Keyword(s):

Clinical Study ◽

Survival Rate ◽

Bone Resorption ◽

Treatment Method ◽

Fixed Dental Prosthesis ◽

Probing Depth ◽

Retrospective Clinical Study ◽

Significant Difference ◽

Implant Prosthesis ◽

Observation Period

This retrospective clinical study was conducted to evaluate the clinical usefulness of a freely removable microlocking implant prosthesis (MLP) that was developed to overcome the problems with conventional implant prostheses. A total of 54 patients (male: 31, female: 23) and 100 implant prostheses were included. Patients were divided into three groups such as 6-12 months, 12-18 months, and 18-24 months according to the used period after implant prosthesis delivery, and the patients in each group were recalled for examinations of survival rate, marginal bone resorption, peri-implant soft tissue indices, and complications. The prosthetic complications were analysed by combining the recorded chart data during the periodic checks including the last call for this study. During a 2-year observation period, all the implants showed a 100% survival rate without clinical mobility and functional problems. There was no significant difference in marginal bone resorption, plaque index, and bleeding index over the observation period after implant prosthesis delivery. Probing depth of the 18-24 months group ( 1.5 ± 0.19 mm ) was significantly lower than that of the 6-12 months group ( p < 0.05 ). The main complication was abutment loosening (4%), followed by implant prosthesis fracture (2%) and food impaction (2%) which were recorded. Within the limits of the present study, the implant prostheses with MLP are considered to be an applicable and predictable treatment method.

Download Full-text